Tag | Content |
---|
EnhancerAtlas ID | HS044-08284 |
Organism | Homo sapiens |
Tissue/cell | Fetal_kidney |
Coordinate | chr21:16815010-16817290 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr21:16816286-16816298 | AAACAAACAAAC | - | 6.32 | GLI2 | MA0734.2 | chr21:16817067-16817082 | CCAGGTGGGTGGTCC | - | 6.53 | Gfi1b | MA0483.1 | chr21:16816419-16816430 | AAATCTCAGCA | + | 6.32 | SOX10 | MA0442.2 | chr21:16815901-16815912 | AAAACAAAGAA | + | 6.62 | ZNF263 | MA0528.1 | chr21:16815285-16815306 | GGAAGAGAGGGGGCAGGAGGA | + | 6.25 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_13189 | chr21:16810477-16816229 | CD34_Primary_RO01480 | SE_13938 | chr21:16806843-16817519 | CD34_Primary_RO01536 | SE_14336 | chr21:16807886-16817241 | CD34_Primary_RO01549 | SE_35514 | chr21:16811734-16818283 | HepG2 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I015439 | chr21 | 16812007 | 16819131 |
|
Enhancer Sequence | AACAAGAGTA AAATTCCACC TCAAAAAAAA AAAGTTTACA CAGAAACAAA ACTCTAAAGT 60 TTATTTCACA AACAGGGGCC ATCTCTCCCT AAAACCTCTA TTCCGGGTGA GTCTCTTTTT 120 TGTTTGTTCC TCCGTAAACT TCCAGGGAGA CTGCCAAACA GTAATGCTCA CCCCGGGGTG 180 ACTGCAGGAC TCACCCAGAG ACAAAACTAC CTTCCTACCT AATGGGCCCT AGACATATGA 240 AGCCTGTCAG GAGAACATCA TAAATCATGG AGATGGGAAG AGAGGGGGCA GGAGGAGCCA 300 CACAAACCCT TTGCACTTAG GAGAAAGAGT TATTTAACAC GTCAGGGAAG TGCATTTAAT 360 AAATGAAGTC AGTGACTTGA ACATGTCATA TTCGATCTAT ATGGAGGTTA CTGAACTTTC 420 TTTAAAAAGT CATTTTTATG CTGGTTGCTT TTCTTATGAA ATTTTCTACA CCTCTAGTGT 480 ATAAAATGGA TGTGTAAGCA GCTGATTGAG AAATAGCTAA GGTCAAAGTT AATAAGGAAA 540 GCAGAAGGTC TAAAAGCAGG CTGCCTTTTT TTTCCCCTTT GAGTTCAAGA GACTCCATAT 600 GATTTGGGCA TGACATACTA ATGTTTCTGA CATCAGGCCT TTTTTTAAAT CTGCCTTCAA 660 ATAACTGATA CTTGGGTGGT AATGAATGTG GAAGATGTCT CGTTGCTGGA ATTACAAAAA 720 TGAACTTTCC TCTTCTGATT TCATTCATGG GCTAGTTTTT ATGAGTAAAA TGATATCAAA 780 GACTTGGAGG GATGGAATAT TGCCTCAAAA TGTCAAGACA ATATAAGTTA CAGAATGTAC 840 AAGTTGGAGA AGAAAGAAAA GGGTGGGAAC ATAGAATTAG GTGTCCCTTT AAAAACAAAG 900 AAGAAAGCAA AATACTCAGC AAGTATATAA ACAAGTACAA ACTGCACATC TATTTTGGAA 960 AATGTTTTTG TATCTCCAGG CTTTCTGGAT CCCTTACATT TAAGTCATGA GAATCTCTGG 1020 GTTATTTTGT CACATAAAAG AGTATAAAAC CCCCATCAAA TCAACAAATA GGTTTGCTCC 1080 CTCAGATGAG ATTTAACTGA AACTTGGAAC AAAAACAGTG AGGTTCATCA GATAAACATA 1140 TGCCAAATTT AAGACTTCTA TCTGTTCTTA AATGGATGCT ATAGATTGTC TGCAAGAACT 1200 ACTCCCTTCA ACTTCAGATG TGATAAAGCT TGATATGATG CTCTTAGACC TTGAAACAGA 1260 AACCATATGT GGCAATAAAC AAACAAACAA AATCCCTGGA TACTGCAAAG GAAAAAAAAA 1320 CAGAAAACTT ACTCGATTTT AGAAGACTTG AAAAAGTTGT AATTATCTTC CTTGATGTAC 1380 ACGGTGTTCA CTGACAGGAA AAAAAAAAGA AATCTCAGCA CCTAAAAACT TATATATTTG 1440 CACATTTATG TTCAAATTAT TCTCTAAATG GCTTGAAATA ATTGCCTCTT CTGCTTTGTA 1500 TTAACTAAAC TTTTTTTTTT TTTTTTTTGT CAAGTCATGG TTCTTTTTCT AGTATCTGAA 1560 AATGTGCCAA ACTAAATGTC AGTGCCTTCA TAAGGAAGAT TTAGAGTTCC TTTTGGAGCA 1620 GATAGAAGCC TCAAATGACA AACACGCTTA TCCTGAATGC CCCTCCTGCT GGTGTGACTT 1680 ACCTCAGAAC AAGGTCAAAG AAGCCGCCAG AGAAGATCTA CGATTTGTTT GACTTGACAT 1740 TCCCTGGTAT TTCCCTTTGT TATCCCTGTG TCATCGTTCT GTGGCAGAGG GAGAGCAAGG 1800 CAAGCGCTTG CTTTCAGGTA TATCTGGCTA GTAGCCCTAC ATACCACAGA GAGCTACTGT 1860 GGATTTCACT GTATGAAAAG CCTCCATTTG ACTTGAATGC TGTTAAAGCA TTGCAGGGGT 1920 AAGTTTTGAA ATCCTTCCTT AGGTCAAACT CTAGCTGGAA AGTTCGCCCC ATCCTCCTCT 1980 TGGAAGGACT CTTATATGGC CTTGTAGCTA AACTTGAGCA ACCACACACT GCAGCAGAGC 2040 AGCTGGCATG GCCCAAGCCA GGTGGGTGGT CCAGGCAAGG CCCAGTCCCC TTGTGTCCAT 2100 TATTGCTAAG GTGCATCTAG GAGCACAAGG ACAGGAGGAG TCAGACATGT GAGTGTTTTT 2160 GCAATCAGTC AACAAACATC CACTGTTTAC CGATTACAGG ACATTTCTTC TGGGCATTGG 2220 GAATACCAAG TGACAAAGTC ATGCTTTTAA TTTTCAAGGT GTTTAATAGA GAATAAGCCA 2280
|